Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Me too.
Someone knows something.
i see on Etrade Bid .0245 ask 3.0
looks like a gapper.
News. Ligand, Lupin settle patent case over Evomela. Is this why LGNDZ has had some movement the last two days?
Probably for a Phase I/2 trial. Raising money with shares is the reason company goes public. As long as they are selling into the market, I am okay with that, if they are diluting with toxic financing = read flag. But if people are worried about dilution ,they can just invest in the preferred shares RGBPP.
Wow
Company Details
Established in 2016 , Hada Brothers Private Ltd. has made a name for itself in the list of top service providers of Common Medicines & Drugs in India. Hada Brothers Private Ltd. is listed in Trade India's list of verified companies offering wide array of VLA2001 COVID-19 Vaccine, Avigan (Favipiravir) Antiviral 200 MG, AstraZeneca COVID-19 Vaccine (Vaxzevria) etc. Contact here for Common Medicines & Drugs in Howrah, West Bengal.
News looks like house keeping before they go current to better protect themselves against attacks.
Gilead To Scale Up Remdesivir Availablity In India
April 27 2021 - 03:17AM
TipRanks
Biopharmaceutical company Gilead Sciences is expanding the availability of its COVID-19 treatment Remdesivir in India amid the country’s spike in cases. Gilead (GILD) is providing technical assistance and support for setting up new local manufacturing plants. The company is also donating the active pharmaceutical ingredient (API) to local facilities to help increase the production of the drug in India. Additionally, the company is donating at least 450,000 vials of Veklury to help Indian patients. Remdesivir is marketed in the US under the brand name Veklury.
https://www.tipranks.com/news/gilead-to-scale-up-remdesivir-availablity-in-india
The kiss of death. Couldn’t you have left this one alone.
That’s what I thought so why hire an auditor now?
Audited or unaudited?
Correct me if I am wrong, but do the financials need to be audited for pink static or are they thinking higher tier or buyout?
They are claiming 10% I believe.
Select Financials
• Fairlystablerevenuebasewithsignificant growth potential, able to weather various economic conditions
• $2.1millioninrevenueinQ12021alone
• Grossmarginprofilegenerally10%+
• Givenauctionnature,particularlyunique products that trigger bidding wars can reach 75%+ gross margins
• SFLMwentpublicinearly2021;initiating audit with goal of filing Form 10, becoming a fully reporting company & uplisting
https://api.mziq.com/mzfilemanager/v2/d/48d0dcf1-e1ff-48ff-b7c8-a23b748ee7ea/ba465d17-e510-0738-6955-63e9a7b55c2e?origin=1
Nice.
Select Financials
• Fairlystablerevenuebasewithsignificant growth potential, able to weather various economic conditions
• $2.1millioninrevenueinQ12021alone
• Grossmarginprofilegenerally10%+
• Givenauctionnature,particularlyunique products that trigger bidding wars can reach 75%+ gross margins
• SFLMwentpublicinearly2021;initiating audit with goal of filing Form 10, becoming a fully reporting company & uplisting
Thx. I still have my divy shares of this. Fidelity won’t let me buy it even though I own it.
Anyone know anything about going current?
It’s just a paid advertisement made to look like a journalist ic report.
Yes, great transparency. Not sure what more the market wants from these guys. Weekly revenue, transparency, and quarter after quarter growth.
What the hell am I missing?
To clarify, does this say we made 223 k on April 8th and 246k for week ending April 3 rd.?
Great news. We should get a PR saying that next Wednesday. I love the way this board tells us first. Thx
What catalyst are you looking for? TIA
I sent a message to him also
Do you have a link for that? We all should send in material.
Watch for dilution today. The thing I don’t understand is if these sales are so good why do we need dilution. The financials also look like crap for making $130 million in 18 years.
Nice work.
As long as big pharm doesn’t squash it.
Nice. I was hoping to see our name, until I saw the big pharmaceutical names.
Interesting read.
https://apple.news/AsLTEq97iTBaTVr_5myLACA
They have hit us with a lot of news and videos this week with the price going down. Looks like dilution to me. Not sure why they need to dilute if they have made 130 million in the last 18 years as well as making $800,000 a month. Financials also looked week for a company making that type of money. Any thoughts?
Anyone see we have news today. Lol
No PR with weekly numbers makes me believe financials out this week, Today or tomorrow .
Sticky please.